This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lian, J. B. Articles by Stein, J. L. Search for Related Content PubMed PubMed Citation Articles by Lian, J. B. Articles by Stein, J. L.

Species-Specific Glucocorticoid and 1,25-Dihydroxyvitamin D Responsiveness in Mouse MC3T3-E1 Osteoblasts: Dexamethasone Inhibits Osteoblast Differentiation and Vitamin D Down-Regulates Osteocalcin Gene Expression¹

University of Massachusetts Medical Center, Department of Cell Biology and Cancer Center, Worcester, Massachusetts 01655-0106

Address all correspondence and requests for reprints to authors at the Department of Cell Biology, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, Massachusetts 01655-0106.

The mouse MC3T3-E1 cell line is nontumorigenic and undergoes a typical program of osteoblast differentiation in vitro, producing a bone-like mineralized extracellular matrix. We report responses of these cells to dexamethasone (Dex) and 1,25-(OH)₂D₃ that are in contrast to findings from other osteoblast culture systems. First, chronic exposure of both early- and late-passaged MC3T3-E1 cells to 10^-7 M Dex, initiated during the proliferation period, blocked osteoblast differentiation, in contrast to the enhanced differentiation observed in cultures of fetal rat calvarial-derived cells. Secondly, 1,25-(OH)₂D₃ did not up-regulate expression (messenger RNA or protein synthesis) of the endogenous mouse osteocalcin (OC) gene. Several lines of evidence are presented that suggest this response is caused by sequence specific properties of the mouse OC vitamin D response element. We also observed both qualitative and quantitative differences in expression of cell growth (histone H2B) and phenotype-related genes (collagen, OC, osteopontin, glucocorticoid receptor, and 1, 25-(OH)₂D₃ receptor), between pre- and postmineralization stage osteoblasts, in response to 24 h steroid hormone treatment. Our findings in MC3T3-E1 cells are consistent with current concepts of selective influences of 1,25-(OH)₂D₃ and glucocorticoids as a function of osteoblast maturation. However, the inhibition of osteoblast differentiation by chronic Dex at 10^-7 M and the down-regulation of OC by 1,25-(OH)₂D₃ are novel observations relevant to species-specific responsiveness of mouse bone-expressed genes to steroid hormones during osteoblast differentiation.

This article has been cited by other articles:

				J. Y. Kim, Y. L. Son, and Y. C. Lee Involvement of SMRT Corepressor in Transcriptional Repression by the Vitamin D Receptor Mol. Endocrinol., February 1, 2009; 23(2): 251 - 264. [Abstract] [Full Text] [PDF]

				A. E. Kearns, S. Khosla, and P. J. Kostenuik Receptor Activator of Nuclear Factor {kappa}B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease Endocr. Rev., April 1, 2008; 29(2): 155 - 192. [Abstract] [Full Text] [PDF]

				W.-C. Huang, Z. Xie, H. Konaka, J. Sodek, H. E. Zhau, and L. W.K. Chung Human Osteocalcin and Bone Sialoprotein Mediating Osteomimicry of Prostate Cancer Cells: Role of cAMP-Dependent Protein Kinase A Signaling Pathway Cancer Res., March 15, 2005; 65(6): 2303 - 2313. [Abstract] [Full Text] [PDF]

				E. Smith and B. Frenkel Glucocorticoids Inhibit the Transcriptional Activity of LEF/TCF in Differentiating Osteoblasts in a Glycogen Synthase Kinase-3{beta}-dependent and -independent Manner J. Biol. Chem., January 21, 2005; 280(3): 2388 - 2394. [Abstract] [Full Text] [PDF]

				D. Jiang, R. T. Franceschi, H. Boules, and G. Xiao Parathyroid Hormone Induction of the Osteocalcin Gene: REQUIREMENT FOR AN OSTEOBLAST-SPECIFIC ELEMENT 1 SEQUENCE IN THE PROMOTER AND INVOLVEMENT OF MULTIPLE SIGNALING PATHWAYS J. Biol. Chem., February 13, 2004; 279(7): 5329 - 5337. [Abstract] [Full Text] [PDF]

				C. A. Luppen, N. Leclerc, T. Noh, A. Barski, A. Khokhar, A. L. Boskey, E. Smith, and B. Frenkel Brief Bone Morphogenetic Protein 2 Treatment of Glucocorticoid-inhibited MC3T3-E1 Osteoblasts Rescues Commitment-associated Cell Cycle and Mineralization without Alteration of Runx2 J. Biol. Chem., November 7, 2003; 278(45): 44995 - 45003. [Abstract] [Full Text] [PDF]

				J.-C. Hsieh, G. K. Whitfield, P. W. Jurutka, C. A. Haussler, M. L. Thatcher, P. D. Thompson, H. T. L. Dang, M. A. Galligan, A. K. Oza, and M. R. Haussler Two Basic Amino Acids C-Terminal of the Proximal Box Specify Functional Binding of the Vitamin D Receptor to Its Rat Osteocalcin Deoxyribonucleic Acid- Responsive Element Endocrinology, November 1, 2003; 144(11): 5065 - 5080. [Abstract] [Full Text] [PDF]

				D. L. Diefenderfer, A. M. Osyczka, J. P. Garino, and P. S. Leboy Regulation of BMP-Induced Transcription in Cultured Human Bone Marrow Stromal Cells J. Bone Joint Surg. Am., August 1, 2003; 85(90003): 19 - 28. [Abstract] [Full Text] [PDF]

				E. M. GARDINER, P. A. BALDOCK, G. P. THOMAS, N. A. SIMS, N. K. HENDERSON, B. HOLLIS, C. P. WHITE, K. L. SUNN, N. A. MORRISON, W. R. WALSH, et al. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage FASEB J, October 1, 2000; 14(13): 1908 - 1916. [Abstract] [Full Text]

				A. Struijs, A. Smals, S. A. de Witte, W. H. L. Hackeng, and H. Mulder Acute effects of etidronate on glucocorticoid-induced bone degradation Rheumatology, May 1, 2000; 39(5): 523 - 529. [Abstract] [Full Text] [PDF]

				G. Boguslawski, L. V. Hale, X.-P. Yu, R. R. Miles, J. E. Onyia, R. F. Santerre, and S. Chandrasekhar Activation of Osteocalcin Transcription Involves Interaction of Protein Kinase A- and Protein Kinase C-dependent Pathways J. Biol. Chem., January 14, 2000; 275(2): 999 - 1006. [Abstract] [Full Text] [PDF]

				A. Javed, S. Gutierrez, M. Montecino, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian Multiple Cbfa/AML Sites in the Rat Osteocalcin Promoter Are Required for Basal and Vitamin D-Responsive Transcription and Contribute to Chromatin Organization Mol. Cell. Biol., November 1, 1999; 19(11): 7491 - 7500. [Abstract] [Full Text] [PDF]

				B. Ecarot and M. Desbarats 1,25-(OH)2D3 Down-Regulates Expression of Phex, a Marker of the Mature Osteoblast Endocrinology, March 1, 1999; 140(3): 1192 - 1199. [Abstract] [Full Text]

				F. Aslam, L. McCabe, B. Frenkel, A. J. van Wijnen, G. S. Stein, J. B. Lian, and J. L. Stein AP-1 and Vitamin D Receptor (VDR) Signaling Pathways Converge at the Rat Osteocalcin VDR Element: Requirement for the Internal Activating Protein-1 Site for Vitamin D-Mediated Trans-Activation Endocrinology, January 1, 1999; 140(1): 63 - 70. [Abstract] [Full Text]

				R.T. Franceschi The Developmental Control of Osteoblast-Specific Gene Expression: Role of Specific Transcription Factors and the Extracellular Matrix Environment Critical Reviews in Oral Biology & Medicine, January 1, 1999; 10(1): 40 - 57. [Abstract] [Full Text] [PDF]

				N. Yanaka, H. Akatsuka, E. Kawai, and K. Omori 1,25-Dihydroxyvitamin D3 upregulates natriuretic peptide receptor-C expression in mouse osteoblasts Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E965 - E973. [Abstract] [Full Text] [PDF]

				E. Luegmayr, F. Varga, H. Glantschnig, N. Fratzl–Zelman, M. Rumpler, A. Ellinger, and K. Klaushofer 1,25-Dihydroxy Vitamin D3 and Tri-iodothyronine Stimulate the Expression of a Protein Immunologically Related to Osteocalcin J. Histochem. Cytochem., April 1, 1998; 46(4): 477 - 486. [Abstract] [Full Text]

				B.-Y. Liu, J. Guo, B. Lanske, P. Divieti, H. M. Kronenberg, and F. R. Bringhurst Conditionally Immortalized Murine Bone Marrow Stromal Cells Mediate Parathyroid Hormone-Dependent Osteoclastogenesis in Vitro Endocrinology, April 1, 1998; 139(4): 1952 - 1964. [Abstract] [Full Text] [PDF]

				T. O. Carpenter, K. C. Moltz, B. Ellis, M. Andreoli, T. L. McCarthy, M. Centrella, D. Bryan, and C. M. Gundberg Osteocalcin Production in Primary Osteoblast Cultures Derived from Normal and Hyp Mice Endocrinology, January 1, 1998; 139(1): 35 - 43. [Abstract] [Full Text] [PDF]

				N. A. Sims, C. P. White, K. L. Sunn, G. P. Thomas, M. L. Drummond, N. A. Morrison, J. A. Eisman, and E. M. Gardiner Human and Murine Osteocalcin Gene Expression: Conserved Tissue Restricted Expression and Divergent Responses to 1,25-Dihydroxyvitamin D3 in Vivo Mol. Endocrinol., October 1, 1997; 11(11): 1695 - 1708. [Abstract] [Full Text]

				E. Smith, R. A. Redman, C. R. Logg, G. A. Coetzee, N. Kasahara, and B. Frenkel Glucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell Cycle. DISSOCIATION OF CYCLIN A-CYCLIN-DEPENDENT KINASE 2 FROM E2F4-p130 COMPLEXES J. Biol. Chem., June 23, 2000; 275(26): 19992 - 20001. [Abstract] [Full Text] [PDF]